Cystinuria
20
4
5
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 20 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
60%
6 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (20)
Lipoic Acid Supplement for Cystine Stone
Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children
The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study
Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics
Prospective Research Rare Kidney Stones (ProRKS)
Rare Kidney Stone Consortium Biobank
Rare Kidney Stone Consortium Patient Registry
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Study Evaluating Patients With Cystinuria
Registry of Thiola EC Therapy
National Registry of Rare Kidney Diseases
Health-related Quality of Life in Rare Kidney Stone
Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria
Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria
Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria
TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study
Cystine Capacity Clinical Study (CysCap)
This Study Evaluates the Superiority of Daily Self-pH Monitorization of Lit-control®pH Meter Compared to the Monitorization of Reactive Strips (Standard of Care).
Bucillamine Phase 2 Trial in Patients With Cystinuria
Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones